Rastreamento sistemático de condições orofaciais insidiosas em pacientes com câncer de cabeça e pescoço: um estudo de coorte prospectivo

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Universidade Federal de Juiz de Fora (UFJF)

DOI

Abstract

CONTEXT: Head and neck cancer (HNC) is the seventh most common type of cancer worldwide. A systematic approach to HNC patients can aid in diagnosing insidious orofacial diseases and complications— conditions often overlooked not only by patients but also by the cancer treatment team. OBJECTIVES: To establish and implement a protocol for the systematic assessment of HNC patients in order to monitor the longitudinal progression of oral toxicities during radiotherapy. MATERIALS AND METHODS: A systematic protocol for the dental assessment of HNC patients was developed, incorporating validated clinical instruments, structured questionnaires, and detailed physical examinations. A prospective longitudinal study begun with 42 patients assessed prior to the start of radiotherapy (T0); and 35 of these completed follow-up through the end of treatment (T2). Clinical assessments were performed at three time points (T0, T1, and T2), covering oral mucositis, xerostomia, dysphagia, trismus, orofacial pain, and oral health-related quality of life (OHIP-14). Temporal progression was analyzed using Cochran's Q and Friedman tests. Generalized Estimating Equation (GEE) models and Generalized Linear Mixed Models (GLMM) were employed to identify predictors of outcomes, while Kaplan-Meier analysis estimated the time to the development of grade ≥2 oral mucositis. RESULTS: A statistically significant worsening was observed in oral mucositis (40.0% to 77.1%; p<0.001), trismus (17.1% to 31.4%; p=0.044), dysphagia (68.6% to 88.6%; p=0.050), and mucositis severity (p<0.001), accompanied by a significant decline in quality of life (OHIP-14; p=0.025). Xerostomia showed a progressive increase, affecting 88.6% of patients. Adjusted models demonstrated a strong effect of time on this outcome (OR=0.098; p<0.001). Orofacial pain maintained a stable prevalence (71.4%); its intensity was associated with female sex (β=1.758; p=0.033) and mucositis grade (β=0.572; p=0.005), but not with treatment duration. The absence of mucositis was strongly associated with a lower occurrence of dysphagia (OR=82.04; p=0.003), whereas head and neck tumors were associated with greater mucositis severity (p=0.023). The mean time to develop grade ≥2 mucositis was 32.08 days, with no difference between sexes (p=0.676). During radiotherapy, only 4 (11.4%) patients required a nasoenteral tube. CONCLUSIONS: The systematized protocol revealed the clinical, epidemiological, and dental profile of HNC patients, highlighting a diversity of lesions and therapeutic complications, as well as the need for specific assessment and management procedures. In the prospective cohort study, significant progression of the main orofacial toxicities was observed. Oral mucositis proved to be the primary clinical determinant of other functional complications, particularly dysphagia and pain intensity. Orofacial pain showed a high prevalence from the initial assessment onwards, presenting specific characteristics at each stage but behaving independently of the treatment's temporal progression. These findings underscore the importance of longitudinal dental monitoring, early identification of predictive factors, and the implementation of individualized preventive and therapeutic strategies to reduce oral morbidity, preserve functionality, and facilitate the continuity of cancer treatment.

Description

Citation

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Except where otherwise noted, this item's license is described as Acesso Aberto